I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Robin E. Osterhout
70
results:
Search for persons
X
Format
Online (70)
Mediatypes
Articles (Online) (63)
OpenAccess-fulltext (7)
Sorted by: Year
Sorted by: Relevance
?
1
Effects of large-scale gold mining on habitat use and selec..:
Osterhout, Megan J.
;
Stewart, Kelley M.
;
Wakeling, Brian F.
...
Science of The Total Environment. 921 (2024) - p. 170750 , 2024
Link:
https://doi.org/10.1016/..
?
2
Seralutinib in adults with pulmonary arterial hypertension ..:
Frantz, Robert P
;
McLaughlin, Vallerie V
;
Sahay, Sandeep
...
The Lancet Respiratory Medicine. 12 (2024) 7 - p. 523-534 , 2024
Link:
https://doi.org/10.1016/..
?
3
Switching patterns of immediate‐release forms of generic mi..:
Perez‐Vilar, Silvia
;
Kempner, Maria E.
;
Dutcher, Sarah K.
...
Pharmacoepidemiology and Drug Safety. 32 (2023) 10 - p. 1178-1183 , 2023
Link:
https://doi.org/10.1002/..
?
4
Pharmacology and Rationale for Seralutinib in the Treatment..:
Pullamsetti, Soni Savai
;
Sitapara, Ravikumar
;
Osterhout, Robin
...
International Journal of Molecular Sciences. 24 (2023) 16 - p. 12653 , 2023
Link:
https://doi.org/10.3390/..
?
5
Context-dependent activation of STING-interferon signaling ..:
Liu, Xiuting
;
Hogg, Graham D.
;
Zuo, Chong
...
Cancer Cell. 41 (2023) 6 - p. 1073-1090.e12 , 2023
Link:
https://doi.org/10.1016/..
?
6
Results of a Phase 2b Trial With GB001, a Prostaglandin D2 ..:
Moss, Mark H.
;
Lugogo, Njira L.
;
Castro, Mario
...
CHEST. 162 (2022) 2 - p. 297-308 , 2022
Link:
https://doi.org/10.1016/..
?
7
Editorial: protecting hypoxia‐inducible factor 1a and gut i..:
Danese, Silvio
;
Levesque, Barrett G.
;
Feagan, Brian G.
...
Alimentary Pharmacology & Therapeutics. 55 (2022) 6 - p. 735-736 , 2022
Link:
https://doi.org/10.1111/..
?
8
Inhaled seralutinib exhibits potent efficacy in models of p..:
Galkin, Anna
;
Sitapara, Ravikumar
;
Clemons, Bryan
...
European Respiratory Journal. 60 (2022) 6 - p. 2102356 , 2022
Link:
https://doi.org/10.1183/..
?
9
Randomised clinical trial: a phase 1b study of GB004, an or..:
Danese, Silvio
;
Levesque, Barrett G.
;
Feagan, Brian G.
...
Alimentary Pharmacology & Therapeutics. 55 (2022) 4 - p. 401-411 , 2022
Link:
https://doi.org/10.1111/..
?
10
Cover Image:
Danese, Silvio
;
Levesque, Barrett G.
;
Feagan, Brian G.
...
Alimentary Pharmacology & Therapeutics. 55 (2022) 4 - p. , 2022
Link:
https://doi.org/10.1111/..
?
11
An orally bioavailable ENPP1-selective inhibitor demonstrat..:
Hu, X.
;
Garcia, E.
;
Goossens, A.
...
European Journal of Cancer. 174 (2022) - p. S125 , 2022
Link:
https://doi.org/10.1016/..
?
12
Molecular characterization of type I IFN-induced cytotoxici..:
Green, Jennifer L.
;
Osterhout, Robin E.
;
Klova, Amy L.
...
Molecular Therapy - Oncolytics. 23 (2021) - p. 547-559 , 2021
Link:
https://doi.org/10.1016/..
?
13
Naegleria fowleri: Protein structures to facilitate drug di..:
Tillery, Logan
;
Barrett, Kayleigh
;
Goldstein, Jenna
...
PLOS ONE. 16 (2021) 3 - p. e0241738 , 2021
Link:
https://doi.org/10.1371/..
?
14
Molecular characterization of type I IFN-induced cytotoxici..:
Jennifer L. Green
;
Robin E. Osterhout
;
Amy L. Klova
...
http://www.sciencedirect.com/science/article/pii/S2372770521001558. , 2021
Link:
https://doi.org/10.1016/..
?
15
The Author(s) Pharmacovigilance and Risk Management Strateg..:
Chazin, Howard D.
;
Peters, John R.
;
Catterson, Debra M.
...
Therapeutic Innovation & Regulatory Science. 53 (2019) 2 - p. 249-253 , 2019
Link:
https://doi.org/10.1177/..
1-15